Nasdaq · CIK 0001812364
RLAY Relay Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing 4 d ago. Close $17.88 on Oct 9, 2026, +197% from the 52-week low and -14% from the high.
Last 90 days
Net insider value
-$2.6M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
5
$2.6M by 3 insiders
Insiders on file
14
with a Form 4 at this company
Price and insider trades, last year
RLAYOct 9, 2026 · close 17.88
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Relay Therapeutics, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Thomas Catinazzo Chief Financial Officer sell | $329k 17,717 shares | -14% | +235% from low-10% from high | |
| 36Weak | Sanjiv Patel President and CEO sell | $872k 48,199 shares | -9% | +208% from low-13% from high | |
| 26Weak | Donald A Bergstrom President, R&D sell | $162k 8,530 shares | -2% | +379% from low-8% from high | |
| 37Weak | Thomas Catinazzo Chief Financial Officer sell | $336k 17,717 shares | -13% | +379% from low-8% from high | |
| 44Moderate | Sanjiv Patel President and CEO sell | $913k 48,199 shares | -8% | +379% from low-8% from high | |
| 41Moderate | Donald A Bergstrom President, R&D sell | $225k 30,897 shares | -6% | +276% from low0% from high | |
| 41Moderate | Thomas Catinazzo Chief Financial Officer sell | $158k 21,664 shares | -6% | +276% from low0% from high | |
| 38Weak | Brian Adams Chief Legal Officer sell | $73k 19,913 shares | -5% | +85% from low-54% from high | |
| 45Moderate | Donald A Bergstrom President, R&D sell | $113k 30,770 shares | -5% | +85% from low-54% from high | |
| 45Moderate | Thomas Catinazzo Chief Financial Officer sell | $74k 20,081 shares | -6% | +85% from low-54% from high | |
| 38Weak | Peter Rahmer See remarks sell | $63k 17,083 shares | -4% | +85% from low-54% from high | |
| 37Weak | Sanjiv Patel President and CEO sell | $219k 61,379 shares | -7% | +91% from low-53% from high | |
| 36Weak | Brian Adams Chief Legal Officer sell | $44k 14,587 shares | -4% | +63% from low-60% from high | |
| 45Moderate | Donald A Bergstrom President, R&D sell | $95k 31,562 shares | -5% | +63% from low-60% from high | |
| 24Weak | Thomas Catinazzo Chief Financial Officer sell | $59k 19,191 shares | -5% | +63% from low-60% from high | |
| 36Weak | Peter Rahmer See remarks sell | $37k 12,103 shares | -3% | +63% from low-60% from high | |
| 52Moderate | Sanjiv Patel President and CEO sell | $182k 61,422 shares | -7% | +56% from low-62% from high | |
| 30Weak | Brian Adams Chief Legal Officer sell | $846 298 shares | -0% | +5% from low-63% from high | |
| 35Weak | Donald A Bergstrom President, R&D sell | $2,800 986 shares | -0% | +5% from low-63% from high | |
| 17Weak | Thomas Catinazzo Chief Financial Officer sell | $14k 4,864 shares | -1% | +5% from low-63% from high | |
| 48Moderate | Brian Adams Chief Legal Officer sell | $248k 54,479 shares | -17% | +21% from low-43% from high | |
| 55Moderate | Donald A Bergstrom President, R&D sell | $362k 80,450 shares | -15% | +21% from low-43% from high | |
| 35Weak | Thomas Catinazzo Chief Financial Officer sell | $268k 58,936 shares | -20% | +21% from low-43% from high | |
| 30Weak | Brian Adams Chief Legal Officer sell | $1,310 299 shares | -0% | - | |
| 35Weak | Donald A Bergstrom President, R&D sell | $2,878 657 shares | -0% | - | |
| 17Weak | Thomas Catinazzo Chief Financial Officer sell | $21k 4,865 shares | -2% | - | |
| 30Weak | Peter Rahmer See remarks sell | $1,752 400 shares | -0% | - | |
| 43Moderate | Sanjiv Patel President and CEO sell | $500k 100,000 shares | -15% | - | |
| 30Weak | Brian Adams Chief Legal Officer sell | $9,890 1,632 shares | -1% | - | |
| 35Weak | Donald A Bergstrom President, R&D sell | $16k 2,688 shares | -1% | - | |
| 24Weak | Thomas Catinazzo Chief Financial Officer sell | $55k 9,102 shares | -3% | - | |
| 30Weak | Peter Rahmer See remarks sell | $9,823 1,621 shares | -0% | - |
Transactions
The last 72 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -17,511 | $18.58 | $325k | 105,340 | 4 d ago |
| Oct 7, 2026 | Sanjiv Patel President and CEO | SOpen-market sale Common Stock10b5-1 | -48,199 | $18.10 | $872k | 471,301 | 4 d ago |
| Oct 6, 2026 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -206 | $19.26 | $3,968 | 105,134 | 4 d ago |
| Sep 8, 2026 | Donald A Bergstrom President, R&D | SOpen-market sale Common Stock10b5-1 | -8,530 | $18.97 | $162k | 399,130 | 33 d ago |
| Sep 8, 2026 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -17,717 | $18.94 | $336k | 122,851 | 33 d ago |
| Sep 8, 2026 | Sanjiv Patel President and CEO | SOpen-market sale Common Stock10b5-1 | -48,199 | $18.94 | $913k | 519,500 | 33 d ago |
| Nov 4, 2025 | Lonnel Coats director | AGrant or award Stock Option (Right to Buy)derivative | +207,931 | $0.00 | $0 | 207,931 | Nov 6, 2025 |
| Nov 4, 2025 | Habib J Dable director | AGrant or award Stock Option (Right to Buy)derivative | +207,931 | $0.00 | $0 | 207,931 | Nov 6, 2025 |
| Oct 28, 2025 | Donald A Bergstrom President, R&D | SOpen-market sale Common Stock | -30,897 | $7.29 | $225k | 521,823 | Oct 30, 2025 |
| Oct 28, 2025 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock | -21,664 | $7.29 | $158k | 313,631 | Oct 30, 2025 |
| Jul 28, 2025 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock | -1,701 | $3.74 | $6,362 | 353,675 | Jul 30, 2025 |
| Jul 28, 2025 | Peter Rahmer See remarks | SOpen-market sale Common Stock | -1,359 | $3.74 | $5,083 | 393,722 | Jul 30, 2025 |
| Jul 28, 2025 | Donald A Bergstrom President, R&D | SOpen-market sale Common Stock | -4,069 | $3.74 | $15k | 579,421 | Jul 30, 2025 |
| Jul 28, 2025 | Brian Adams Chief Legal Officer | SOpen-market sale Common Stock | -1,637 | $3.74 | $6,122 | 389,748 | Jul 30, 2025 |
| Jul 29, 2025 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock | -18,380 | $3.68 | $68k | 335,295 | Jul 30, 2025 |
| Jul 29, 2025 | Brian Adams Chief Legal Officer | SOpen-market sale Common Stock | -18,276 | $3.68 | $67k | 371,472 | Jul 30, 2025 |
| Jul 29, 2025 | Donald A Bergstrom President, R&D | SOpen-market sale Common Stock | -26,701 | $3.68 | $98k | 552,720 | Jul 30, 2025 |
| Jul 29, 2025 | Peter Rahmer See remarks | SOpen-market sale Common Stock | -15,724 | $3.68 | $58k | 377,998 | Jul 30, 2025 |
| Jul 9, 2025 | Sanjiv Patel President and CEO | SOpen-market sale Common Stock | -42,740 | $3.57 | $153k | 783,927 | Jul 10, 2025 |
| Jul 9, 2025 | Sanjiv Patel President and CEO | SOpen-market sale Common Stock | -18,639 | $3.57 | $67k | 765,288 | Jul 10, 2025 |
| Jun 30, 2025 | Sanjiv Patel President and CEO | AGrant or award Common Stock | +5,000 | $2.94 | $15k | 826,667 | Jul 1, 2025 |
| Jun 30, 2025 | Peter Rahmer See remarks | AGrant or award Common Stock | +5,000 | $2.94 | $15k | 395,081 | Jul 1, 2025 |
| Jun 9, 2025 | Claire Mazumdar director | AGrant or award Stock Option (Right to Buy)derivative | +421,241 | $0.00 | $0 | 421,241 | Jun 11, 2025 |
| Jun 6, 2025 | Alexis Borisy director | AGrant or award Stock Option (Right to Buy)derivative | +136,681 | $0.00 | $0 | 136,681 | Jun 6, 2025 |
| Jun 6, 2025 | Jami Rubin director | AGrant or award Stock Option (Right to Buy)derivative | +136,681 | $0.00 | $0 | 136,681 | Jun 6, 2025 |
| Jun 6, 2025 | Mark Murcko director | AGrant or award Stock Option (Right to Buy)derivative | +136,681 | $0.00 | $0 | 136,681 | Jun 6, 2025 |
| Jun 6, 2025 | Sekar Kathiresan director | AGrant or award Stock Option (Right to Buy)derivative | +136,681 | $0.00 | $0 | 136,681 | Jun 6, 2025 |
| Jun 6, 2025 | Douglas S Ingram director | AGrant or award Stock Option (Right to Buy)derivative | +136,681 | $0.00 | $0 | 136,681 | Jun 6, 2025 |
| Jun 6, 2025 | Linda A Hill director | AGrant or award Stock Option (Right to Buy)derivative | +136,681 | $0.00 | $0 | 136,681 | Jun 6, 2025 |
| Apr 28, 2025 | Peter Rahmer See remarks | SOpen-market sale Common Stock | -1,364 | $3.17 | $4,324 | 400,820 | Apr 30, 2025 |
| Apr 28, 2025 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -1,709 | $3.17 | $5,418 | 372,858 | Apr 30, 2025 |
| Apr 28, 2025 | Donald A Bergstrom President, R&D | SOpen-market sale Common Stock | -4,090 | $3.17 | $13k | 610,962 | Apr 30, 2025 |
| Apr 28, 2025 | Brian Adams Chief Legal Officer | SOpen-market sale Common Stock | -1,644 | $3.17 | $5,211 | 404,328 | Apr 30, 2025 |
| Apr 30, 2025 | Peter Rahmer See remarks | SOpen-market sale Common Stock | -10,739 | $3.00 | $32k | 390,081 | Apr 30, 2025 |
| Apr 30, 2025 | Donald A Bergstrom President, R&D | SOpen-market sale Common Stock | -27,472 | $3.00 | $82k | 583,490 | Apr 30, 2025 |
| Apr 28, 2025 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -981 | $3.17 | $3,110 | 371,877 | Apr 30, 2025 |
| Apr 30, 2025 | Brian Adams Chief Legal Officer | SOpen-market sale Common Stock | -12,943 | $3.00 | $39k | 391,385 | Apr 30, 2025 |
| Apr 29, 2025 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -3,558 | $3.23 | $11k | 368,319 | Apr 30, 2025 |
| Apr 30, 2025 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -12,943 | $3.00 | $39k | 355,376 | Apr 30, 2025 |
| Apr 23, 2025 | Sanjiv Patel President and CEO | SOpen-market sale Common Stock | -42,769 | $2.97 | $127k | 840,320 | Apr 24, 2025 |
| Apr 23, 2025 | Sanjiv Patel President and CEO | SOpen-market sale Common Stock | -18,653 | $2.97 | $55k | 821,667 | Apr 24, 2025 |
| Mar 27, 2025 | Brian Adams Chief Legal Officer | SOpen-market sale Common Stock | -298 | $2.84 | $846 | 405,972 | Mar 31, 2025 |
| Mar 27, 2025 | Donald A Bergstrom President, R&D | SOpen-market sale Common Stock | -986 | $2.84 | $2,800 | 615,052 | Mar 31, 2025 |
| Mar 27, 2025 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -298 | $2.84 | $846 | 379,133 | Mar 31, 2025 |
| Mar 27, 2025 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -4,566 | $2.84 | $13k | 374,567 | Mar 31, 2025 |
| Jan 28, 2025 | Donald A Bergstrom President, R&D | SOpen-market sale Common Stock | -3,220 | $4.63 | $15k | 516,868 | Jan 30, 2025 |
| Jan 28, 2025 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -33,753 | $4.63 | $156k | 265,473 | Jan 30, 2025 |
| Jan 28, 2025 | Brian Adams Chief Legal Officer | SOpen-market sale Common Stock | -33,688 | $4.63 | $156k | 287,920 | Jan 30, 2025 |
| Jan 28, 2025 | Brian Adams Chief Legal Officer | AGrant or award Common Stock | +139,141 | $0.00 | $0 | 427,061 | Jan 30, 2025 |
| Jan 28, 2025 | Donald A Bergstrom President, R&D | AGrant or award Common Stock | +176,400 | $0.00 | $0 | 693,268 | Jan 30, 2025 |
| Jan 28, 2025 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -2,283 | $4.63 | $11k | 263,190 | Jan 30, 2025 |
| Jan 30, 2025 | Brian Adams Chief Legal Officer | SOpen-market sale Common Stock | -20,791 | $4.42 | $92k | 406,270 | Jan 30, 2025 |
| Jan 28, 2025 | Thomas Catinazzo Chief Financial Officer | AGrant or award Common Stock10b5-1 | +139,141 | $0.00 | $0 | 402,331 | Jan 30, 2025 |
| Jan 29, 2025 | Donald A Bergstrom President, R&D | SOpen-market sale Common Stock | -46,407 | $4.55 | $211k | 646,861 | Jan 30, 2025 |
| Jan 29, 2025 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -2,109 | $4.55 | $9,596 | 400,222 | Jan 30, 2025 |
| Jan 30, 2025 | Donald A Bergstrom President, R&D | SOpen-market sale Common Stock | -30,823 | $4.42 | $136k | 616,038 | Jan 30, 2025 |
| Jan 30, 2025 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -20,791 | $4.42 | $92k | 379,431 | Jan 30, 2025 |
| Jan 10, 2025 | Brian Adams Chief Legal Officer | AGrant or award Stock Option (Right to Buy)derivative | +275,000 | $0.00 | $0 | 275,000 | Jan 14, 2025 |
| Jan 10, 2025 | Donald A Bergstrom President, R&D | AGrant or award Stock Option (Right to Buy)derivative | +400,000 | $0.00 | $0 | 400,000 | Jan 14, 2025 |
| Jan 10, 2025 | Thomas Catinazzo Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +275,000 | $0.00 | $0 | 275,000 | Jan 14, 2025 |
| Dec 27, 2024 | Brian Adams Chief Legal Officer | SOpen-market sale Common Stock | -299 | $4.38 | $1,310 | 321,608 | Dec 31, 2024 |
| Dec 27, 2024 | Peter Rahmer See remarks | SOpen-market sale Common Stock | -400 | $4.38 | $1,752 | 389,663 | Dec 31, 2024 |
| Dec 27, 2024 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -299 | $4.38 | $1,310 | 303,792 | Dec 31, 2024 |
| Dec 27, 2024 | Donald A Bergstrom President, R&D | SOpen-market sale Common Stock | -657 | $4.38 | $2,878 | 520,088 | Dec 31, 2024 |
| Dec 27, 2024 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -4,566 | $4.42 | $20k | 299,226 | Dec 31, 2024 |
| Dec 16, 2024 | Sanjiv Patel President and CEO | SOpen-market sale Common Stockindirect: By The Patel Family Irrevocable Trust of 201910b5-1 | -100,000 | $5.00 | $500k | 574,548 | Dec 18, 2024 |
| Oct 28, 2024 | Brian Adams Chief Legal Officer | SOpen-market sale Common Stock | -1,632 | $6.06 | $9,890 | 321,907 | Oct 30, 2024 |
| Oct 28, 2024 | Donald A Bergstrom President, R&D | SOpen-market sale Common Stock | -2,688 | $6.06 | $16k | 520,745 | Oct 30, 2024 |
| Oct 28, 2024 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -1,697 | $6.06 | $10k | 311,496 | Oct 30, 2024 |
| Oct 28, 2024 | Peter Rahmer See remarks | SOpen-market sale Common Stock | -1,621 | $6.06 | $9,823 | 390,063 | Oct 30, 2024 |
| Oct 28, 2024 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -5,105 | $6.06 | $31k | 306,391 | Oct 30, 2024 |
| Oct 29, 2024 | Thomas Catinazzo Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -2,300 | $5.95 | $14k | 304,091 | Oct 30, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Brian AdamsChief Legal Officer
- Donald A BergstromPresident, R&D
- Alexis Borisydirector
- Lonnel Coatsdirector
- Thomas CatinazzoChief Financial Officer
- Habib J Dabledirector
- Linda A Hilldirector
- Douglas S Ingramdirector
- Sekar Kathiresanceo, officer, director
- Claire Mazumdardirector, ceo, officer
- Mark Murckodirector
- Sanjiv PatelPresident and CEO
- Peter RahmerSee remarks
- Jami Rubindirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.